Literature DB >> 6740333

An activated rasN gene: detected in late but not early passage human PA1 teratocarcinoma cells.

M A Tainsky, C S Cooper, B C Giovanella, G F Vande Woude.   

Abstract

Early passages of the human teratocarcinoma cell line PA1 are not tumorigenic in nude mice, while late passages are. A transforming gene present in late passages of PA1 cells was isolated as a biologically active molecular clone and is a new isolate of the human rasN locus. Its transforming activity is due to a single G---A (G, guanine; A, adenine) point mutation at the codon for amino acid 12 which changes the codon for glycine so that an aspartic acid residue is expressed. In contrast to late passage PA1 cells (passages 106, 330, and 338), DNA from the PA1 cell line at early passages (passage 36) does not yield rasN foci in DNA transfection assays. Thus, the presence of an activated rasN in PA1 cells correlates with enhanced tumorigenicity of the cell line and, more importantly, may have arisen during cell culture in vitro.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6740333     DOI: 10.1126/science.6740333

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

1.  Secretion of polypeptides related to epidermal growth factor and insulinlike growth factor I by a human teratocarcinoma cell line.

Authors:  N H Jing; R Shiurba; H Kitani; H Kawakatsu; Y Tomooka; T Sakakura
Journal:  In Vitro Cell Dev Biol       Date:  1991-11

2.  The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation.

Authors:  E N Olson; G Spizz; M A Tainsky
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

Review 3.  Implications of tumor progression on clinical oncology.

Authors:  D R Welch; S P Tomasovic
Journal:  Clin Exp Metastasis       Date:  1985 Jul-Sep       Impact factor: 5.150

4.  Alteration of homeobox gene expression by N-ras transformation of PA-1 human teratocarcinoma cells.

Authors:  R Buettner; S O Yim; Y S Hong; E Boncinelli; M A Tainsky
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

5.  An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2.

Authors:  R Buettner; P Kannan; A Imhof; R Bauer; S O Yim; R Glockshuber; M W Van Dyke; M A Tainsky
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  The genomic structure of the human AP-2 transcription factor.

Authors:  R Bauer; A Imhof; A Pscherer; H Kopp; M Moser; S Seegers; M Kerscher; M A Tainsky; F Hofstaedter; R Buettner
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

Review 7.  Cancer genes: rare recombinants instead of activated oncogenes (a review).

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Human recipient cell for oncogene transfection studies.

Authors:  M A Tainsky; F L Shamanski; D Blair; G Vande Woude
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

9.  Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen.

Authors:  I Guerrero; A Villasante; V Corces; A Pellicer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Mutations activating human c-Ha-ras1 protooncogene (HRAS1) induced by chemical carcinogens and depurination.

Authors:  K H Vousden; J L Bos; C J Marshall; D H Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.